MedPath

K PREvention of Cancer by Intervention with SElenium

Completed
Conditions
Multiple cancer sites
Cancer
Malignant neoplasm without specification of site
Registration Number
ISRCTN25193534
Lead Sponsor
Cancer Research UK (CRUK) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
500
Inclusion Criteria

Volunteers aged 60 - 74 years old, either sex

Exclusion Criteria

Added 12/07/2010:
1. Southwest Oncology Group (SWOG) grading scale performance status score greater than 1 or equivalent
2. Active liver or kidney disease (known abnormal liver or kidney function)
3. Prior diagnosis of cancer (excluding non-melanoma skin cancer)
4. Diagnosed human immunodeficiency virus (HIV) infection
5. Diminished mental capacity (subjects must be able to give informed consent to participate as defined by ethics committees)
6. Taking 50 µg/day or more of selenium supplements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath